Seagen, Inc.



 Seagen Inc. 

Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. We are leveraging our expertise in antibodies to build a portfolio of proprietary antibody-drug conjugates and immuno-oncology agents in clinical trials for hematologic malignancies and solid tumors. For more information, visit  

Learn More - Recent Updates from Seagen
Seagen and RemeGen announce exclusive worldwide license and co-development agreement for disitamab vedotin 

Seagen and Astellas collaborate on trial in non-muscle invasive bladder cancer (NMIBC) 

Social media

Contact details

Products & Services

Documents & Links